MiljenkoPilepichMD

PubMed

• 36 citations
  Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group tr...
  Daniel A. Hamstra, Kyounghwa Bae, Miljenko V. Pilepich, Gerald E. Hanks, David J. Grignon, David G. McGowan, Mack Roach, Colleen A. Lawton, R. Jeffrey Lee, Howard M. S...> ;International Journal of Radiation Oncology, Biology, Physics. 2011 Dec 1
• 20 citations
  Timing of Salvage Hormonal Therapy in Prostate Cancer Patients With Unfavorable Prognosis Treated With Radiotherapy: A Secondary Analysis of Radiation Therapy Oncology...
  Luis Souhami, Kyounghwa Bae, Miljenko V. Pilepich, Howard M. Sandler> ;International Journal of Radiation Oncology, Biology, Physics. 2010 Dec 1
• 65 citations
  Impact of the Duration of Adjuvant Hormonal Therapy in Patients With Locally Advanced Prostate Cancer Treated With Radiotherapy: A Secondary Analysis of RTOG 85-31
  Luis Souhami, Kyounghwa Bae, Miljenko V. Pilepich, Howard M. Sandler> ;Journal of Clinical Oncology. 2009 May 1
• 190 citations
  Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31
  Jason A. Efstathiou, Kyounghwa Bae, William U. Shipley, Gerald E. Hanks, Miljenko V. Pilepich, Howard M. Sandler, Matthew R. Smith> ;Journal of Clinical Oncology. 2009 Jan 1
• 157 citations
  Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02
  Jason A. Efstathiou, Kyounghwa Bae, William U. Shipley, Gerald E. Hanks, Miljenko V. Pilepich, Howard M. Sandler, Matthew R. Smith> ;European Urology. 2008 Oct 1
• 44 citations
  Diabetes and Mortality in Men With Locally Advanced Prostate Cancer: RTOG 92-02
  Matthew R. Smith, Kyounghwa Bae, Jason A. Efstathiou, Gerald E. Hanks, Miljenko V. Pilepich, Howard M. Sandler, William U. Shipley> ;Journal of Clinical Oncology. 2008 Sep 10
• 27 citations
  Protein Kinase A RI-α Predicts for Prostate Cancer Outcome: Analysis of Radiation Therapy Oncology Group Trial 86-10
  Li Yan Khor, Kyounghwa Bae, Tahseen Al-Saleem, Elizabeth H. Hammond, David J. Grignon, William T. Sause, Miljenko V. Pilepich, Paul P. Okunieff, Howard M. Sandler, Ala...> ;International Journal of Radiation Oncology, Biology, Physics. 2008 Aug 1
• 56 citations
  Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy on...
  Colleen A. Lawton, K. Bae, Miljenko V. Pilepich, Gerald E. Hanks, William U. Shipley> ;International Journal of Radiation Oncology, Biology, Physics. 2008 Feb 1
• 453 citations
  Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610
  Mack Roach, Kyounghwa Bae, Joycelyn L. Speight, Harvey B. Wolkov, P. Rubin, R. Jeffrey Lee, Colleen A. Lawton, Richard K. Valicenti, David J. Grignon, Miljenko V. Pile...> ;Journal of Clinical Oncology. 2008 Feb 1
• 81 citations
  Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31.
  Jason A. Efstathiou, Kyounghwa Bae, William U. Shipley, Gerald E. Hanks, Miljenko V. Pilepich, Howard M. Sandler, Matthew R. Smith> ;Cancer. 2007 Dec 15
• 29 citations
  Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10.
  Li Yan Khor, Michelle DeSilvio, Rile Li, Timothy J. McDonnell, M. Elizabeth H. Hammond, William T. Sause, Miljenko V. Pilepich, Paul Okunieff, Howard M. Sandler, Alan ...> ;International Journal of Radiation Oncology, Biology, Physics. 2006 Sep 1
• 6 citations
  Phase III study of pentosanpolysulfate (PPS) in treatment of gastrointestinal tract sequelae of radiotherapy.
  Miljenko V. Pilepich, Rebecca Paulus, William H. St. Clair, R.A. Brasacchio, Robert Rostock, Robert C. Miller> ;American Journal of Clinical Oncology. 2006 Apr 1
• 680 citations
  Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.
  Miljenko V. Pilepich, Kathryn Winter, Colleen A. Lawton, Robert E. Krisch, Harvey B. Wolkov, Benjamin Movsas, Eugen B. Hug, Sucha O. Asbell, David J. Grignon> ;International Journal of Radiation Oncology, Biology, Physics. 2005 Apr 1
• 121 citations
  Androgen Suppression Plus Radiation Versus Radiation Alone for Patients With Stage D1/Pathologic Node-Positive Adenocarcinoma of the Prostate: Updated Results Based on...
  Colleen A. Lawton, Kathryn Winter, David J. Grignon, Miljenko V. Pilepich> ;Journal of Clinical Oncology. 2005 Feb 1
• 50 citations
  Loss of p16 Expression Is of Prognostic Significance in Locally Advanced Prostate Cancer: An Analysis From the Radiation Therapy Oncology Group Protocol 86–10
  Arnab Chakravarti, K. Heydon, Chin-Lee Wu, Elizabeth H. Hammond, A. Pollack, M. Roach, Harvey B. Wolkov, Paul Okunieff, Jerome R. Cox, James Fontanesi, Ross A. Abrams,...> ;Journal of Clinical Oncology. 2003 Sep 1
• 39 citations
  Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials.
  Mack Roach, Jiandong Lu, Miljenko V. Pilepich, Sucha O. Asbell, Mohammed Mohiuddin, David J. Grignon> ;The Journal of Urology. 2003 Jan 1
• 591 citations
  Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate
  Miljenko V. Pilepich, Kathryn Winter, Madhu John, John B. Mesic, William T. Sause, P. Rubin, Colleen A. Lawton, Mitchell Machtay, David J. Grignon> ;International Journal of Radiation Oncology, Biology, Physics. 2001 Aug 1
• 279 citations
  Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiat...
  Colleen A. Lawton, Kathryn Winter, Kevin Murray, Mitchell Machtay, John B. Mesic, Gerald E. Hanks, Christopher T. Coughlin, Miljenko V. Pilepich> ;International Journal of Radiation Oncology, Biology, Physics. 2001 Mar 15
• 113 citations
  Survival Advantage From Higher-Dose Radiation Therapy for Clinically Localized Prostate Cancer Treated on the Radiation Therapy Oncology Group Trials
  Richard K. Valicenti, Jiandong Lu, Miljenko V. Pilepich, Sucha O. Asbell, David J. Grignon> ;Journal of Clinical Oncology. 2000 Jul 14
• 134 citations
  Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on radiation therapy oncology group clinical trials
  Mack Roach, Jiandong Lu, Miljenko V. Pilepich, Sucha O. Asbell, Mohammed Mohuidden, Roger Terry, David J. Grignon> ;International Journal of Radiation Oncology, Biology, Physics. 2000 Jun 1
• 66 citations
  Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31
  Benjamin W. Corn, Kathryn Winter, Miljenko V. Pilepich> ;Urology. 1999 Sep 1
• 28 citations
  Ten-year outcomes for pathologic node-positive patients treated in RTOG 75-06
  M.D. Gerald E. Hanks, Jan Buzydlowski, William Sause, Bahman Emami, Philip Rubin, John A Parsons, Anthony H Russell, Roger W Byhardt, John D Earle, Miljenko V. Pilepich> ;International Journal of Radiation Oncology, Biology, Physics. 1998 Mar 1
• 56 citations
  Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG #77-06, a phase III study for T1BN0M0 (A2) and T2N0M0 (B) prostate carcinoma.
  Sucha O Asbell, Karen L Martz, Kyu H Shin, William Sause, R.L. Doggett, Carlos A Perez, Miljenko V. Pilepich> ;International Journal of Radiation Oncology, Biology, Physics. 1998 Mar 1
• 492 citations
  Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Th...
  Miljenko V. Pilepich, Richard J. Caplan, R. W. Byhardt, Colleen A. Lawton, M J Gallagher, John B. Mesic, Gerald E. Hanks, Christopher T. Coughlin, Arthur T. Porter, Wi...> ;Journal of Clinical Oncology. 1997 Mar 1
• 132 citations
  p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610.
  David J. Grignon, Richard J. Caplan, Fazlul H. Sarkar, Colleen A. Lawton, Elizabeth H. Hammond, Miljenko V. Pilepich, Jeffrey D. Forman, John B. Mesic, Karen K. Fu, Ro...> ;Journal of the National Cancer Institute. 1997 Jan 15
• Join now to see all